Menopause and the skin

Author: Vanessa Ngan, Staff Writer, 2002.


Strictly speaking, menopause is defined as the day a woman has been diagnosed as not having a menstrual period for 12 consecutive months. This signifies the permanent cessation of menstruation. The period leading up to menopause is described several ways, menopausal transition, peri-menopause or climacteric. During this time, which may precede several years before menopause, fluctuations in menstrual cycles and hormonal changes occur. This is evident from the signs and symptoms that a woman may experience.

Common peri-menopausal signs and symptoms also include:

The term genitourinary syndrome of menopause describes:

What effect does menopause have on the skin?

On average menopause occurs as women reach early to mid-50 years. Leading into this time changes in hormone production occur, most notably a decline in oestrogen levels (hypo-oestrogenism).

Oestrogen affects every organ system of the body including the skin. Oestrogen receptors are most abundant around the genital area, face and lower limbs. Therefore these areas are especially vulnerable to reduced amounts of circulating oestrogen and are the reason for certain skin conditions involving these areas to be more common in peri- and post-menopausal women than in women of other age groups.

Atrophic vulvovaginitis


Vulvovaginal candidiasis

Bacterial vaginosis

Vulvar lichen sclerosus

Dyaesthetic vulvodynia

Hirsutism (abnormal hair growth in women)

Alopecia (hair loss from areas where it is normally present)

Menopausal flushing

Keratoderma climactericum

What treatment is available for menopausal symptoms?

Hormone replacement therapy (HRT) has been shown to prevent many of the signs and symptoms experienced in peri- and post-menopause, including urogenital and general skin and hair problems. Systemic HRT may consist of oestrogen tablets, patches, vaginal rings, implants, or a combination of oestrogen and progestogen as patch or tablet.

HRT is no longer recommended for healthy asymptomatic women.

Oestrogen cream is particularly useful for atrophic vulvovaginitis, and systemic absorption and side effects are minimal.

Other treatments for genitourinary syndrome of menopause may include:

Related information

Email Newsletter

Would you like to receive our dermatology updates by email?


Submit your images

We're seeking high-quality photos of skin diseases.  


Machine diagnosis

Watch DermNet's proposal to create a 'Skin Disease Image Recognition Tool' - winner of the 2017 'Clinicians' Challenge Active Award' by the NZ Ministry of Health and HiNZ.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter